MARTHA AIYUK: Open Payments
NPI 1932650215 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 41 payments from 20 companies in 2025. Trend: 2023 $130 · 2024 $424 · 2025 $1,261
Food & beverage: $1,185Education: $76
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $170 |
| Janssen Biotech, Inc. | 3 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $146 |
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Daiichi Sankyo Inc. | 1 | $76 |
| Genentech USA, Inc. | 3 | $66 |
| Incyte Corporation | 2 | $44 |
| Lilly USA, LLC | 2 | $32 |
Products named: KEYTRUDA, BREYANZI, RYBREVANT, Enhertu, CALQUENCE, TAGRISSO, LUTATHERA, KISQALI.
Industry payments across NV — which companies pay providers there.
